Shandong Jincheng Pharmaceutical Group Co., Ltd (SHE:300233)

SHE:300233 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	669.37	917.67	1,025	859.13	981.18	1,075
Cash & Short-Term Investments	741.37	917.67	1,025	859.13	981.18	1,075
Cash Growth	-21.24%	-10.44%	19.27%	-12.44%	-8.75%	8.56%
Accounts Receivable	580.74	696.8	794.56	803.39	684	790.05
Other Receivables	4.16	6.45	7.81	4.62	5.08	2.07
Receivables	584.9	703.25	802.37	808.01	689.08	792.12
Inventory	528.47	598.86	501.28	579.22	391.32	284.08
Prepaid Expenses	-	-	0.2	0.55	0.01	1.37
Other Current Assets	39.98	38.5	40.77	61.24	77.68	69.04
Total Current Assets	1,895	2,258	2,369	2,308	2,139	2,222
Property, Plant & Equipment	2,220	2,310	2,468	2,469	2,093	1,777
Long-Term Investments	183.77	183.28	147.52	141.22	143.31	129.39
Other Intangible Assets	513.75	513.51	547.29	452.2	449.75	494.35
Long-Term Deferred Tax Assets	50.38	63.94	69.77	51.96	30.71	40.93
Long-Term Deferred Charges	244.28	252.96	310.89	369.59	329.72	286.79
Other Long-Term Assets	34.56	23.5	3.51	34.42	89.77	49.8
Total Assets	5,141	5,605	5,916	5,826	5,275	5,000
Accounts Payable	435.06	552.56	824	726.05	515.31	299.63
Accrued Expenses	181.63	355.9	402.32	394.98	362.19	400.69
Short-Term Debt	120.07	55.04	94	212.89	223	154
Current Portion of Long-Term Debt	91.67	101.52	109.24	163.2	155.45	-
Current Portion of Leases	-	0.13	0.72	1.11	2.37	-
Current Income Taxes Payable	30.13	21.53	24.85	18.84	18.72	18.83
Current Unearned Revenue	31.62	50.94	32.74	44.67	54.47	35.03
Other Current Liabilities	194.47	93.35	112.47	139.2	84.94	240.73
Total Current Liabilities	1,085	1,231	1,600	1,701	1,416	1,149
Long-Term Debt	163.34	351.99	346.7	271.69	208.29	255.39
Long-Term Leases	5.76	6.88	3.46	2.02	63.52	-
Long-Term Unearned Revenue	53.94	53.88	61.6	66	54.81	51.41
Long-Term Deferred Tax Liabilities	113.94	129.1	122.94	126.21	92.66	77.11
Other Long-Term Liabilities	2.03	-	-	-	-	-
Total Liabilities	1,424	1,773	2,135	2,167	1,836	1,533
Common Stock	383.87	383.87	383.87	387.41	387.41	391.55
Additional Paid-In Capital	2,328	2,328	2,328	2,397	2,404	2,474
Retained Earnings	930.77	1,051	967.95	850.41	653.34	622.84
Treasury Stock	-55.01	-55.01	-	-56.94	-80.01	-73.55
Comprehensive Income & Other	62.88	59.49	34.62	29.33	29.44	23.45
Total Common Equity	3,650	3,767	3,714	3,607	3,394	3,438
Minority Interest	67.19	65.17	66.93	51.87	44.96	29.32
Shareholders' Equity	3,717	3,832	3,781	3,659	3,439	3,467
Total Liabilities & Equity	5,141	5,605	5,916	5,826	5,275	5,000
Total Debt	380.83	515.56	554.12	650.91	652.62	409.39
Net Cash (Debt)	360.54	402.11	470.54	208.22	328.55	665.85
Net Cash Growth	4.35%	-14.54%	125.98%	-36.62%	-50.66%	80.04%
Net Cash Per Share	0.92	1.06	1.21	0.54	0.85	1.72
Filing Date Shares Outstanding	379.33	379.33	383.87	383.1	383.87	387.41
Total Common Shares Outstanding	379.33	379.33	383.87	383.1	383.87	387.41
Working Capital	810.09	1,027	768.95	607.21	722.83	1,073
Book Value Per Share	9.62	9.93	9.68	9.42	8.84	8.87
Tangible Book Value	3,136	3,253	3,167	3,155	2,945	2,944
Tangible Book Value Per Share	8.27	8.58	8.25	8.24	7.67	7.60
Buildings	-	1,424	1,406	1,356	1,021	946.46
Machinery	-	2,414	2,289	2,152	1,671	1,388
Construction In Progress	-	73.33	148.97	121.31	332.32	300.44

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.